Follow everything happening at the Mercatus Center from week to week by subscribing to This Week at Mercatus.
Get the latest in research, commentary, and more from Mercatus scholars.
The FDA's risk aversion costs lives, but the Japanese process for drug approval offers a solution. Read more at The Hill.
Seniors Suffer the Most From Antiquated FDA Approval Process
Diane Abbitt
Bartley Madden
The FDA's risk aversion costs lives, but the Japanese process for drug approval offers a solution. Read more at The Hill.